The role of pharmacist for enhancing medication adherence in COPD (Chronic Obstructive Pulmonary Diseases) patients in pakista

Phase 1

• Conditions: Chronic Obstructive Pulmonary Disease (COPD).; Chronic obstructive pulmonary disease, unspecified; J44.9

• Registration Number: IRCT20220516054875N1
• Lead Sponsor: Quaid-i-Azam University , Islamabad

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Patients only attend the outpatient COPD wards, confirmed diagnosis of COPD by the hospital consultant for at least 1 year
Newly diagnosed patients with a forced expiratory volume in 1 s (FEV1) of 30–80% of the predicted normal value
Patients that hospital consultant agree that the patient is suitable for entering the trial

Exclusion Criteria

Moderate to severe learning difficulties
Mobility problems, confusion, disorientation or terminal illness
Congestive heart failure or if they are attending a pulmonary rehabilitation programs consulting a pulmonary nurse or clinical pharmacist in the last 6 months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The medication adherence by pharmacist intervention will be improved. Timepoint: Before intervention, after 24 weeks of intervention. Method of measurement: Self-structured medication adherence Questionnaire will be filled to check the adherence level.

Secondary Outcome Measures

Name	Time	Method
Assessment of patient quality of life by St. George Respiratory Questionnare. Timepoint: Before intervention and after 24 weeks of intervention. Method of measurement: Patients interviews.